Mechanisms and clinical consequences of vascular calcification

Frontiers in Endocrinology

Volumn 3, Issue AUG, 2012, Pages

  Zhu, Dongxing ^a   Mackenzie, Neil C W ^a   Farquharson, Colin ^a   MacRae, Vicky E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Therapeutic strategies; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

EID: 84874412697     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00095     Document Type: Review

References (186)

1. Adeney, K. L., Siscovick, D. S., Ix, J. H., Seliger, S. L., Shlipak, M. G., Jenny, N. S., and Kestenbaum, B. R. (2009). Association of serum phosphate with vascular and valvular calcification in moderate CKD. J. Am. Soc. Nephrol. 20, 381-387.
2. Allison, M. A., Criqui, M. H., and Wright, C. M. (2004). Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 331-336.
3. Anderson, H. C., Stechschulte, D. J. Jr, Collins, D. E., Jacobs, D. H., Morris, D. C., Hsu, H. H., Redford, P. A., and Zeiger, S. (1990). Matrix vesicle biogenesis in vitro by rachitic and normal rat chondrocytes. Am. J. Pathol. 136, 391-398.
4. Andreeva, E. R., Pugach, I. M., Gordon, D., and Orekhov, A. N. (1998). Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 30, 127-135.
5. Arad, Y, Spadaro, L. A., Goodman, K., Newstein, D., and Guerci, A. D. (2000). Prediction of coronary events with electron beam computed tomography. J. Am. Coll. Cardiol. 36, 1253-1260.
6. Balica,M.,Bostrom,K.,Shin,V.,Tillisch, K., and Demer, L. L. (1997). Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 95, 1954-1960.
7. Bandeira, E., Neves, A. P., Costa, C., and Bandeira, F. (2012). Association between vascular calcification and osteoporosis in men with type 2 diabetes. J. Clin. Densitom. 15, 55-60.
8. Bea, F., Blessing, E., Bennett, B. J., Kuo, C. C., Campbell, L. A., Kreuzer, J., and Rosenfeld, M. E. (2003). Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc. Res. 60, 198-204.
9. Beadenkopf, W. G., Daoud, A. S., and Love, B. M. (1964). Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am. J. Roentgenol. Radium Ther. Nucl. Med. 92, 865-871.
10. Beazley, K. E., Deasey, S., Lima, F., and Nurminskaya, M. V. (2012). Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarininduced vascular calcification. Arterioscler. Thromb. Vasc. Biol. 32, 123-130.
11. Bennett, B. J., Scatena, M., Kirk, E. A., Rattazzi, M., Varon, R. M., Averill, M., Schwartz, S. M., Giachelli, C. M., and Rosenfeld, M. E. (2006). Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/mice. Arterioscler. Thromb. Vasc. Biol. 26, 2117-2124.
12. Beulens, J. W., Bots, M. L., Atsma, F., Bartelink, M. L., Prokop, M., Geleijnse, J. M., Witteman, J. C., Grobbee, D. E., and van der Schouw, Y. T. (2009). High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 203, 489-493.
13. Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., and Chertow, G. M. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol. 15, 2208-2218.
14. Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., and Reid, I. R. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691.
15. Briand, M., Lemieux, I., Dumesnil, J. G., Mathieu, P., Cartier, A., Després, J. P., Arsenault, M., Couet, J., and Pibarot, P. (2006). Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J. Am. Coll. Cardiol. 47, 2229-2236.
16. Bucay, N., Sarosi, I., Dunstan, C. R., Morony,S.,Tarpley,J.,Capparelli,C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., and Simonet, W. S. (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268.
17. Burke,A. P.,Taylor,A.,Farb,A.,Malcom, G. T., and Virmani, R. (2000). Coronary calcification: insights from sudden coronary death victims. Z. Kardiol. 89, 49-53.
18. Canfield, A. E., Doherty, M. J., Wood, A. C., Farrington, C., Ashton, B., Begum, N., Harvey, B., Poole, A., Grant,M. E.,and Boot-Handford,R. P. (2000). Role of pericytes in vascular calcification: a review. Z. Kardiol. 89, 20-27.
19. Canfield,A. E., Farrington, C., Dziobon, M. D., Boot-Handford, R. P., Heagerty, A. M., Kumar, S. N., and Roberts, I. S. (2002). The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J. Pathol. 196, 228-234.
20. Chang, J. K., Wang, G. J., Tsai, S. T., and Ho, M. L. (2005). Nonsteroidal anti-inflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect. Tissue Res. 46, 200-210.
21. Chantelau, E., Lee, K. M., and Jungblut, R. (1995).Association of below-knee atherosclerosis to medial arterial calcification in diabetes mellitus. Diabetes Res. Clin. Pract. 29, 169-172.
22. Chen, N. X., Chen, X., O'Neill, K. D., Atkinson, S. J., and Moe, S. M. (2010). RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC). Am. J. Physiol. Renal Physiol. 299, F674-F680.
23. Chen, N. X., Duan, D., O'Neill, K. D., and Moe, S. M. (2006). High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol. Dial. Transplant. 21, 3435-3442.
24. Chen, N. X., and Moe, S. M. (2003). Arterial calcification in diabetes. Curr. Diab. Rep. 3, 28-32.
25. Coates, T., Kirkland, G. S., Dymock, R. B., Murphy, B. F., Brealey, J. K., Mathew, T. H., and Disney, A. P. (1998). Cutaneous necrosis from calcific uremic arteriolopathy. Am. J. Kidney Dis. 32, 384-391.
26. Cola, C., Almeida, M., Li, D., Romeo, F., and Mehta, J. L. (2004). Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem. Biophys. Res. Commun. 320, 424-427.
27. Collett, G. D., Sage, A. P., Kirkton, J. P., Alexander, M. Y., Gilmore, A. P., and Canfield, A. E. (2007). Axl/phosphatidylinositol 3-kinase signalling inhibits mineral deposition by vascular smooth muscle cells. Circ. Res. 100, 502-509.
28. Cosmi, J. E., Kort, S., Tunick, P. A., Rosenzweig, B. P., Freedberg, R. S., Katz, E. S., Applebaum, R. M., and Kronzon, I. (2002). The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch. Intern. Med. 162, 2345-2347.
29. Czermack, J. (1852). Beschreibung und mikroskopische Untersuchung zweier ägyptischer Mumien. SonderBerichte Akad Wiss Wien 9, 427-469.
30. Dao, H. H., Essalihi, R., Bouvet, C., and Moreau, P. (2005). Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc. Res. 66, 307-317.
31. Demer, L. L., and Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation 117, 2938-2948.
32. Dhingra, R., Sullivan, L. M., Fox, C. S., Wang, T. J., D'Agostino, R. S. Sr., Gaziano, J. M., and Vasan, R. S. (2007). Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch. Intern. Med. 167, 879-885.
33. Doherty, M. J., Ashton, B. A., Walsh, S., Beresford, J. N., Grant, M. E., and Canfield, A. E. (1998). Vascular pericytes express osteogenic potential in vitro and in vivo. J. Bone Miner. Res. 13, 828-838.
34. Doherty, M. J., and Canfield, A. E. (1999). Gene expression during vascular pericyte differentiation. Crit. Rev. Eukaryot. Gene Expr. 9, 1-17.
35. Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J. H., Fishbein, M. C., Detrano, R. C., Shah, P. K., and Rajavashisth, T. B. (2004). Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr. Rev. 25, 629-672.
36. Edouard, T., Chabot, G., Miro, J., Buhas, D. C., Nitschke, Y., Lapierre, C., Rutsch, F., and Alos, N. (2011). Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. Eur. J. Pediatr. 170, 1585-1590.
37. Essalihi, R., Ouellette, V., Dao, H. H., McKee, M. D., and Moreau, P. (2004). Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin J. Cardiovasc. Pharmacol. 44, S147-S150.
38. Farrington-Rock, C., Crofts, N. J., Doherty, M. J., Ashton, B. A., Griffin-Jones, C., and Canfield, A. E. (2004). Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110, 2226-2232.
39. Fitzgerald, P. J., Ports, T. A., and Yock, P. G. (1992). Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 86, 64-70.
40. Forbat, S. M., Naoumova, R. P., Sidhu, P. S., Neuwirth, C., MacMahon, M., Thompson, G. R., and Underwood, S. R. (1998). The effect of cholesterol reduction with fluvastatin on aortic compliance, coronary calcification and carotid intimal-medial thickness: a pilot study. J. Cardiovasc. Risk 5, 1-10.
41. Frye, M. A., Melton, L. J., Bryant, S. C., Fitzpatrick, L. A., Wahner, H. W., Schwartz, R. S., and Riggs, B. L. (1992). Osteoporosis and calcification of the aorta. Bone Miner. 19, 185-194.
42. Fuchs, U., Caffier, P., Schulz, H. G., and Wieniecki, P. (1985). Arterial calcification in diabetics. Virchows Arch. A Pathol. Anat. Histopathol. 407, 431-439.
43. Furie, B., Bouchard, B. A., and Furie, B. C. (1999). Vitamin Kdependent biosynthesis of gammacarboxyglutamic acid. Blood 93, 1798-1808.
44. Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H., van der Meer, I. M., Hofman, A., and Witteman, J. C. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease:the Rotterdam Study. J. Nutr. 134, 3100-3105.
45. Giachelli, C. M. (2004). Vascular calcification mechanisms. J. Am. Soc. Nephrol. 15, 2959-2964.
46. Giachelli, C. M. (2009). The emerging role of phosphate in vascular calcification. Kidney Int. 75, 890-897.
47. Greenland, P., Bonow, R. O., Brundage, B. H., Budoff, M. J., Eisenberg, M. J., Grundy, S. M., Lauer, M. S., Post, W. S., Raggi, P., Redberg, R. F., Rodgers, G. P., Shaw, L. J., Taylor, A. J., Weintraub, W. S., Harrington, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Grines, C. L., Hlatky, M. A., Lichtenberg, R. C., Lindner, J. R., Pohost, G. M., Schofield, R. S., Shubrooks, S. J. Jr, Stein, J. H., Tracy, C. M., Vogel, R. A., and Wesley, D. J. (2007). ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force. Circulation 115, 402-426.
48. Harmey, D., Hessle, L., Narisawa, S., Johnson, K. A., Terkeltaub, R., and Millán, J. L. (2004). Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am. J. Pathol. 164, 1199-1209.
49. Hedin,U.,Roy,J.,Tran,P. K.,Lundmark, K., and Rahman, A. (1999). Control of smooth muscle cell proliferation the role of the basement membrane. Thromb. Haemost. 82, 23-26.
50. Helas, S., Goettsch, C., Schoppet, M., Zeitz,U.,Hempel,U.,Morawietz,H., Kostenuik, P. J., Erben, R. G., and Hofbauer, L. C. (2009). Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am. J. Pathol. 175, 473-478.
51. Ho, M. L., Chang, J. K., and Wang, G. J. (1995). Antiinflammatory drug effects on bone repair and remodeling in rabbits. Clin. Orthop. 313, 270-278.
52. Hofbauer, L. C., Brueck, C. C., Shanahan, C. M., Schoppet, M., and Dobnig, H. (2007). Vascular calcification and osteoporosis from clinical observation towards molecular understanding. Osteoporos. Int. 18, 251-259.
53. Howe, A. M., and Webster, W. S. (2000). Warfarin exposure and calcification of the arterial system in the rat. Int. J. Exp. Pathol. 81, 51-56.
54. Hruska, K. A., Mathew, S., and Saab, G. (2005). Bone morphogenetic proteins in vascular calcification. Circ. Res. 97, 105-114.
55. Hunt, J. L., Fairman, R., Mitchell, M. E., Carpenter, J. P., Golden, M., Khalapyan, T., Wolfe, M., Neschis, D., Milner, R., Scoll, B., Cusack, A., and Mohler, E. R. (2002). Bone formation in carotid plaques: a clinicopathological study. Stroke 33, 1214-1219.
56. Hyder, J. A., Allison, M. A., Criqui, M. H., and Wright, C. M. (2007). Association between systemic calcified atherosclerosis and bone density. Calcif. Tissue Int. 80, 301-306.
57. Jahnen-Dechent, W., Heiss, A., Schäfer, C., and Ketteler, M. (2011). Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 108, 1494-1509.
58. Johnson, K., Polewski, M., van Etten, D., and Terkeltaub, R. (2005). Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/mice. Arterioscler. Thromb. Vasc. Biol. 25, 686-691.
59. Johnson, K. A., Polewski, M., and Terkeltaub, R. A. (2008). Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ. Res. 102, 529-537.
60. Kaden, J. J., Dempfle, C. E., Grobholz, R., Tran, H. T., Kiliç, R., Sarikoç, A., Brueckmann, M., Vahl, C., Hagl, S., Haase, K. K., and Borggrefe, M. (2003). Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 170, 205-211.
61. Kaden,J. J.,Dempfle,C. E.,Grobholz,R., Fischer, C. S., Vocke, D. C., Kiliç, R., Sarikoç, A., Piñol, R., Hagl, S., Lang, S., Brueckmann, M., and Borggrefe, M. (2005). Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc. Pathol. 14, 80-87.
62. Kapustin, A. N., Davies, J. D., Reynolds, J. L., McNair, R., Jones, G. T., Sidibe, A., Schurgers, L. J., Skepper, J. N., Proudfoot, D., Mayr, M., and Shanahan, C. M. (2011). Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. 109, e1-e12.
63. Keelan, P. C., Bielak, L. F., Ashai, K., Jamjoum, L. S., Denktas, A. E., Rumberger, J. A., Sheedy, I. P., Peyser, P. A., and Schwartz, R. S. (2001). Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 104, 412-417.
64. Keller, J., Bünger, C., Andreassen, T. T., Bak, B., and Lucht, U. (1987). Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop. Scand. 58, 379-383.
65. Kelly, R. P., Tunin, R., and Kass, D. A. (1992). Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ. Res. 71, 490-502.
66. Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., and Andress, D. L. (2005). Serum phosphate levels and mortality risk among people with chronic kidney disease. J. Am. Soc. Nephrol. 16, 520-528.
67. Kestenbaum, B. R., Adeney, K. L., de Boer, I. H., Ix, J. H., Shlipak, M. G., and Siscovick, D. S. (2009). Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. Kidney Int. 76, 991-998.
68. Kiel, D. P., Kauppila, L. I., Cupples, L. A., Hannan, M. T., O'Donnell, C. J., and Wilson, P. W. (2001). Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif. Tissue Int. 68, 271-276.
69. Kirton, J. P., Crofts, N. J., George, S. J., Brennan, K., and Canfield, A. E. (2007). Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease Circ. Res. 101, 581-589.
70. Kirton, J. P., Wilkinson, F. L., Canfield, A. E., and Alexander, M. Y. (2006). Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification. Circ. Res. 98, 1264-1272.
71. Kovarnik, T., Mintz, G. S., Skalicka, H., Kral, A., Horak, J., Skulec, R., Uhrova, J., Martasek, P., Downe, R. W., Wahle, A., Sonka, M., Mrazek, V., Aschermann, M., and Linhart, A. (2012). Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. Circ. J. 76, 176-183.
72. Kovesdy, C. P., Kuchmak, O., Lu, J. L., and Kalantar-Zadeh,K. (2010). Outcomes associated with serum calcium level in men with non-dialysisdependent chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 468-476.
73. Kramer, H., Toto, R., Peshock, R., Cooper, R., and Victor, R. (2005). Association between chronic kidney disease and coronaryarterycalcification: the Dallas Heart Study. J. Am. Soc. Nephrol. 16, 507-513.
74. Laroche, M., and Delmotte, A. (2005). Increased arterial calcification in Paget's disease of bone. Calcif. Tissue Int. 77, 129-133.
75. Larsson, T. E., Olauson, H., Hagstrom, E., Ingelsson, E., Arnlov, J., Lind, L., and Sundstrom, J. (2010). Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler. Thromb. Vasc. Biol. 30, 333-339.
76. Lehto, S., Niskanen, L., Suhonen, M., Ronnemaa, T., and Laakso, M. (1996). Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulindependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 16, 978-983.
77. Lencel, P., Delplace, S., Pilet, P., Leterme, D., Miellot, F., Sourice, S., Caudrillier, A., Hardouin, P., Guicheux, J., and Magne, D. (2011). Cellspecific effects of TNF-α and IL-1β on alkaline phosphatase:implication for syndesmophyte formation and vascular calcification. Lab. Invest. 91, 1434-1442.
78. Li, R., Mittelstein, D., Lee, J., Fang, K., Majumdar, R., Tintut, Y., Demer, L. L., and Hsiai, T. K. (2012). A dynamic model of calcific nodule destabilization in response to monocyteand oxidized lipidinduced matrix metalloproteinases. Am. J. Physiol. Cell Physiol. 302, C658-C665.
79. Li, X., Yang, H. Y., and Giachelli, C. M. (2006). Role of the sodiumdependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 98, 905-912.
80. Lindroos, M., Kupari, M., Heikkilä, J., and Tilvis, R. (1993). Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220-1225.
81. Liu, A. C., Joag, V. R., and Gotlieb, A. I. (2007). The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 171, 1407-1418.
82. Loecker, T. H., Schwartz, R. S., Cotta, C. W., and Hickman, J. R. (1992). Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J. Am. Coll. Cardiol. 19, 1167-1172.
83. Lomashvili, K. A., Garg, P., Narisawa, S., Millan, J. L., and O'Neill, W. C. (2008). Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int. 73, 1024-1030.
84. Lomashvili, K. A., Monier-Faugere, M. C., Wang, X., Malluche, H. H., and O'Neill, W. C. (2009). Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int. 75, 617-625.
85. London, G. M., Guerin, A. P., Marchais, S. J., Metivier, F., Pannier, B., and Adda, H. (2003). Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731-1740.
86. London, G. M., Marchais, S. J., Guerin, A. P., and Metivier, F. (2005). Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr. Opin. Nephrol. Hypertens. 14, 525-531.
87. Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., and Karsenty, G. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81.
88. Mackenzie, N. C., and MacRae, V. E. (2011). The role of cellular senescence during vascular calcification: a key paradigm in aging research. Curr. Aging Sci. 4, 128-136.
89. Mackenzie, N. C., Zhu, D., Longley, L., Patterson, C. S., Kommareddy, S., and MacRae,V. E. (2011). MOVAS-1 cell line: a new in vitro model of vascular calcification. Int. J. Mol. Med. 27, 663-668.
90. Matsui,I.,Hamano,T.,Mikami,S.,Fujii, N., Takabatake, Y., Nagasawa, Y., Kawada, N., Ito, T., Rakugi, H., Imai, E., and Isaka, Y. (2009). Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 75, 915-928.
91. Minasi, M. G., Riminucci, M., De Angelis, L., Borello, U., Berarducci, B., Innocenzi, A., Caprioli, A., Sirabella, D., Baiocchi, M., De Maria, R., Boratto, R., Jaffredo, T., Broccoli, V., Bianco, P., and Cossu, G. (2002). The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129, 2773-2783.
92. Moe, S. M., and Chen, N. X. (2004). Pathophysiology of vascular calcification in chronic kidney disease. Circ. Res. 95, 560-567.
93. Mohler,E. B. P. R.,Gannon,F.,Reynolds, C., Zimmerman, R., Keane, M. G., and Kaplan, F. S. (2001). Bone formation and inflammation in cardiac valves. Circulation 103, 1522-1528.
94. Mohler, E. R., Sheridan, M. J., Nichols, R., Harvey, W. P., and Waller, B. F. (1991). Development and progression of aortic valve stenosis: atherosclerosis risk factors a causal relationship A clinical morphologic study. Clin. Cardiol. 14, 995-999.
95. Mönckeberg, J. G. (1903). Über die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 171, 141-167.
96. Murshed, M., Harmey, D., Millán, J. L., McKee, M. D., and Karsenty, G. (2005). Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19, 1093-1104.
97. Mwipatayi, B. P., Cooke, C., Sinniah, R. H., Abbas, M., Angel, D., and Sieunarine, K. (2007). Calciphylaxis: emerging concept in vascular patients. Eur. J. Dermatol. 17, 73-78.
98. Nabeshima, Y. (2002). Ectopic calcification in Klotho mice. Clin. Calcium 12, 1114-1147.
99. Nahar, N. N., Missana, L. R., Garimella, R., Tague, S. E., and Anderson, H. C. (2008). Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins. J. Bone Miner. Metab. 26, 514-519.
100. Nakahara, T., Sato, H., Shimizu, T., Tanaka, T., Matsui, H., KawaiKowase, K., Sato, M., Iso, T., Arai, M., and Kurabayashi, M. (2010). Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 394, 243-248.
101. Nakano-Kurimoto, R., Ikeda, K., Uraoka, M., Nakagawa, Y., Yutaka, K., Koide, M., Takahashi, T., Matoba, S., Yamada, H., Okigaki, M., and Matsubara, H. (2009). Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am. J. Physiol. Heart Circ. Physiol. 297, 1673-1684.
102. Narisawa, S., Harmey, D., Yadav, M. C., O'Neill, W. C., Hoylaerts, M. F., and Millán, J. L. (2007). Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J. Bone Miner. Res. 22, 1700-1710.
103. Nilsson, O. S., Bauer, H. C., Brosjo, O., and Tornkvist, H. (1986). Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age. Clin. Orthop. 207. 239-245.
104. Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., and Enriquez-Sarano, M. (2006). Burden of valvular heart diseases: a population-based study. Lancet 368, 1005-1011.
105. O'Brien,K. D.,Reichenbach,D. D.,Marcovina, S. M., Kuusisto, J., Alpers, C. E., and Otto, C. M. (1996). Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler. Thromb. Vasc. Biol. 16, 523-532.
106. Ohtsuka, S., Kakihana, M., Watanabe, H., and Sugishita, Y. (1994). Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J.Am. Coll. Cardiol. 24, 1406-1414.
107. O'Keefe, J. H., Lavie, C. J., Nishimura, R. A., and Edwards, W. D. (1991). Degenerative aortic stenosis. One effect of the graying of America. Postgrad. Med. 89, 143-146.
108. Okuno, S., Ishimura, E., Kitatani, K., Fujino, Y., Kohno, K., Maeno, Y., Maekawa, K., Yamakawa, T., Imanishi, Y., Inaba, M., and Nishizawa, Y. (2007). Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 49, 417-425.
109. Olsson, M., Dalsgaard, C. J., Haegerstrand, A., Rosenqvist, M., Rydén, L., and Nilsson, J. (1994). Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J. Am. Coll. Cardiol. 23, 1162-1170.
110. Olsson, M., Thyberg, J., and Nilsson, J. (1999). Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler. Thromb. Vasc. Biol. 19, 1218-1222.
111. Osako, M. K., Nakagami, H., Koibuchi, N., Shimizu, H., Nakagami, F., Koriyama, H., Shimamura, M., Miyake, T., Rakugi, H., and Morishita, R. (2010). Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ. Res. 107,466-475.
112. Osman, L., Yacoub, M. H., Latif, N., Amrani, M., and Chester, A. H. (2006). Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 114, I547-I552.
113. Ossareh, S. (2011). Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Iran J. Kidney Dis. 5, 285-299.
114. Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., and O'Brien, K. D. (1994). Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90, 844-853.
115. Pohle, K., Maffert, R., Ropers, D., Moshage, W., Stilianakis, N., Daniel, W. G., and Achenbach, S. (2001). Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104, 1927-1932.
116. Price, P. A., Faus, S. A., and Williamson, M. K. (2001). Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler. Thromb. Vasc. Biol. 21, 817-824.
117. Price, P. A., Roublick, A. M., and Williamson, M. K. (2006). Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int. 70, 1577-1583.
118. Qunibi, W. Y., Nolan, C. A., and Ayus, J. C. (2002). Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Kidney Int. 82, S73-S80.
119. Radcliff, K., Tang, T. B., Lim, J., Zhang, Z., Abedin, M., Demer, L. L., and Tintut,Y. (2005). Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways. Circ. Res. 96, 398-400.
120. Raggi, P., Bellasi, A., Ferramosca, E., Islam, T., Muntner, P., and Block, G. A. (2007). Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int. 71, 802-807.
121. Rajamannan,N. M. (2009). Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler. Thromb. Vasc. Biol. 29, 162-168.
122. Rajamannan, N. M., Subramaniam, M., Rickard, D., Stock, S. R., Donovan, J., Springett, M., Orszulak, T., Fullerton, D. A., Tajik, A. J., Bonow, R. O., and Spelsberg, T. (2003). Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107, 2181-2184.
123. Reaven,P. D.,and Sacks,J. (2005). Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia 48, 379-385.
124. Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., JahnenDechent, W., Weissberg, P. L., and Shanahan, C. M. (2004). Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 15, 2857-2867.
125. Ribeiro, S., Ramos, A., Brandao, A., Rebelo, J. R., Guerra, A., Resina, C., Vila-Lobos, A., Carvalho, F., Remedio, F., and Ribeiro, F. (1998). Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol. Dial. Transplant. 13, 2037-2040.
126. Rikitake, Y., and Liao, J. K. (2005). Rho GTPases, statins, and nitric oxide. Circ. Res. 97, 1232-1235.
127. Roman-Garcia, P., Barrio-Vazquez, S., Fernandez-Martin, J. L., RuizTorres, M. P., and Cannata-Andia, J. B. (2011). Natural antioxidants and vascular calcification: a possible benefit. J. Nephrol. 24, 669-672.
128. Rosenhek, R., Binder, T., Porenta, G., Lang, I., Christ, G., Schemper, M., Maurer, G., and Baumgartner, H. (2000). Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343, 611-617.
129. Rumberger, J. A., Simons, D. B., Fitzpatrick, L. A., Sheedy, P. F., and Schwartz, R. S. (1995). Coronary artery calcium area by electronbeam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92, 2157-2162.
130. Russo, D., Palmiero, G., De Blasio, A. P., Balletta, M. M., and Andreucci, V. E. (2004). Coronary artery calcification in patients with CRF not undergoing dialysis. Am. J. Kidney Dis. 44, 1024-1030.
131. Rutsch,F.,Böyer,P.,Nitschke,Y.,Ruf,N., Lorenz-Depierieux, B., Wittkampf, T., Weissen-Plenz, G., Fischer, R. J., Mughal, Z., Gregory, J. W., Davies, J. H., Loirat, C., Strom, T. M., Schnabel, D., Nürnberg, P., and Terkeltaub, R. (2008). Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ. Cardiovasc. Genet. 1, 133-140.
132. Rutsch,F.,Ruf,N.,Vaingankar,S.,Toliat, M. R., Suk, A., Höhne, W., Schauer, G., Lehmann, M., Roscioli, T., Schnabel, D., Epplen, J. T., Knisely, A., Superti-Furga, A., McGill, J., Filippone, M., Sinaiko, A. R., Vallance, H., Hinrichs, B., Smith, W., Ferre, M., Terkeltaub, R., and Nürnberg, P. (2003). Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat. Genet. 34, 379-381.
133. Sage, A. P., Lu, J., Tintut, Y., and Demer, L. L. (2011). Hyperphosphatemiainduced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. 79, 414-422.
134. Salhiyyah, K., Yacoub, M. H., and Chester, A. H. (2011). Cellular mechanisms in mitral valve disease. J. Cardiovasc. Transl. Res. 4,702-709.
135. Sangiorgi, G., Rumberger, J. A., Severson, A., Edwards, W. D., Gregoire, J., Fitzpatrick, L. A., and Schwartz, R. S. (1998). Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans:a histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol. 31, 126-133.
136. Schmermund,A.,Achenbach,S.,Budde, T., Buziashvili, Y., Förster, A., Friedrich, G., Henein, M., Kerkhoff, G., Knollmann, F., Kukharchuk, V., Lahiri, A., Leischik, R., Moshage, W., Schartl, M., Siffert, W., SteinhagenThiessen, E., Sinitsyn, V., Vogt, A., Wiedeking, B., and Erbel, R. (2006). Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 113, 427-337.
137. Schmermund, A., Baumgart, D., Mohlenkamp, S., Kriener, P., Pump, H., Gronemeyer, D., Seibel, R., and Erbel, R. (2001). Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler. Thromb. Vasc. Biol. 21, 421-426.
138. Schurgers, L. J., Shearer, M. J., Hamulyák, K., Stöcklin, E., and Vermeer, C. (2007). Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1and nattoderived menaquinone-7. Blood 109, 3279-3283.
139. Schurgers, L. J., and Vermeer, C. (2000). Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 30, 298-307.
140. Sevinc Ok, E., Asci, G., Kircelli, F., Duman, S., Dheir, H., Sezis Demirci, M., Ozkahya, M., Toz, H., and Ok, E. (2012). Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients. Int. Urol. Nephro. doi: 10.1007/s11255-012-0138-8
141. Shanahan, C. M., Cary, N. R., Salisbury, J. R., Proudfoot, D., Weissberg, P. L., and Edmonds, M. E. (1999). Medial localization of mineralization-regulating proteins in association with Mönckeberg sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100, 2168-2176.
142. Shanahan, C. M., Weissberg, P. L., and Metcalfe, J. C. (1993). Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ. Res. 73, 193-204.
143. Shang,Q.,Xu,H.,and Huang,L. (2012). Tanshinone IIA: a promising natural cardioprotective agent. Evid. Based Complement. Alternat. Med. 2012, 716459. doi: 10.1155/2012/716459
144. Shao, J. S., Cheng, S. L., Pingsterhaus, J. M., Charlton-Kachigian, N., Loewy, A. P., and Towler, D. A. (2005). Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J. Clin. Invest. 115, 1210-1220.
145. Shimizu, T., Tanaka, T., Iso, T., Matsui, H., Ooyama, Y., Kawai-Kowase, K., Arai, M., and Kurabayashi, M. (2011). Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J. Biol. Chem. 286, 19138-11948.
146. Shroff, R. (2011). Dysregulated mineral metabolism in children with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 20, 233-240.
147. Shroff, R. C., McNair, R., Figg, N., Skepper, J. N., Schurgers, L., Gupta, A., Hiorns, M., Donald, A. E., Deanfield,J.,Rees,L.,and Shanahan,C. M. (2008). Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748-1757.
148. Shroff, R. C., and Shanahan, C. M. (2007). The vascular biology of calcification. Semin. Dial. 20, 103-109.
149. Simmons, C. A., Nikolovski, J., Thornton, A. J., Matlis, S., and Mooney, D. J. (2004). Mechanical stimulation and mitogen-activated protein kinase signaling independently regulate osteogenic differentiation and mineralization by calcifying vascular cells. J. Biomech. 37, 1531-1541.
150. Son, B. K., Kozaki, K., Iijima, K., Eto, M., Nakano, T., Akishita, M., and Ouchi, Y. (2007). Gas6/AxlPI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur. J. Pharmacol. 556, 1-8.
151. Speer, M. Y., and Giachelli, C. M. (2004). Regulation of cardiovascular calcification. Cardiovasc. Pathol. 13, 63-70.
152. Speer, M. Y., McKee, M. D., Guldberg, R. E., Liaw, L., Yang, H. Y., Tung, E., Karsenty, G., and Giachelli, C. M. (2002). Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla proteindeficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196, 1047-1055.
153. Speer, M. Y., Yang, H. Y., Brabb, T., Leaf, E., Look,A., Lin,W. L., Frutkin, A., Dichek, D., and Giachelli, C. M. (2009). Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 104, 733-741.
154. Spronk,H. M.,Soute,B.A.,Schurgers,L. J., Thijssen, H. H., De Mey, J. G., and Vermeer, C. (2003). Tissue-specific utilization of menaquinone-4 results in the prevention of arterialcalcification in warfarin-treated rats. J. Vasc. Res. 40, 531-537.
155. Stary, H. C. (2000). Natural history of calcium deposits in atherosclerosis progression and regression. Z. Kardiol. 89, 28-35.
156. Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., and Wissler, R. W. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355-1374.
157. Steitz, S. A., Speer, M. Y., Curinga, G., Yang, H. Y., Haynes, P., Aebersold, R., Schinke, T., Karsenty, G., and Giachelli, C. M. (2001). Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 89, 1147-1154.
158. Stewart, B. F., Siscovick, D., Lind, B. K., Gardin,J. M.,Gottdiener,J. S.,Smith, V. E., Kitzman, D. W., and Otto, C. M. (1997). Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29, 630-634.
159. Stompór, T., Rajzer, M., Sulowicz, W., Dembinska-Kiec, A., Janda, K., Kawecka-Jaszcz, K., Wójcik, K., Tabor,B.,Zdzienicka,A.,and JanuszGrzybowska, E. (2003). An association between aortic pulse wave velocity, blood pressure and chronic inflammation in ESRD patients on peritoneal dialysis. Int. J. Artif. Organs 26, 188-195.
160. Tamura, K., Suzuki, Y., Matsushita, M., Fujii, H., Miyaura, C., Aizawa, S., and Kogo, H. (2007). Prevention of aortic calcification by etidronate in the renal failure rat model. Eur. J. Pharmacol. 558, 159-166.
161. Tang, F., Wu, X., Wang, T., Wang, P., Li, R., Zhang, H., Gao, J., Chen, S., Bao, L., Huang, H., and Liu, P. (2007). Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul. Pharmacol. 46, 427-438.
162. Tanikawa, T., Okada, Y., Tanikawa, R., and Tanaka,Y. (2009).Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J. Vasc. Res. 46, 572-580.
163. Tanimura, A., McGregor, D. H., and Anderson, H. C. (1983). Matrix vesicles in atherosclerotic calcification. Proc. Soc. Exp. Biol. Med. 172, 173-177.
164. Tentori, F., Blayney, M. J., Albert, J. M., Gillespie, B. W., Kerr, P. G., Bommer, J., Young, E. W., Akizawa, T., Akiba, T.,Pisoni,R. L.,Robinson,B. M.,and Port, F. K. (2008). Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 52, 519-530.
165. Thyberg, J. (1996). Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169, 183-265.
166. Ting, T. C., Miyazaki-Anzai, S., Masuda, M., Levi, M., Demer, L. L., Tintut, Y., and Miyazaki, M. (2011). Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J. Biol. Chem. 286, 23938-23949.
167. Tintut, Y., Alfonso, Z., Saini, T., Radcliff, K., Watson, K., Bostrom, K., and Demer, L. L. (2003). Multilineage potential of cells from the artery wall. Circulation 108, 2505-2510.
168. Tintut, Y., Parhami, F., Boström, K., Jackson, S. M., and Demer, L. L. (1998). cAMP stimulates osteoblastlike differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J. Biol. Chem. 27, 7547-7553.
169. Tintut, Y., Patel, J., Parhami, F., and Demer, L. L. (2000). Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636-2642.
170. Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., and Curhan, G. (2005). Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627-2633.
171. Toussaint, N. D., Lau, K. K., Strauss, B. J., Polkinghorne, K. R., and Kerr, P. G. (2008). Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol. Dial. Transplant. 23, 586-593.
172. Towler, D. A., Bidder, M., Latifi, T., Coleman, T., and Semenkovich, C. F. (1998). Diet induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273, 30427-30434.
173. Vattikuti, R., and Towler, D. A. (2004). Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286, E686-E696.
174. Virchow, R. (1989). Cellular pathology. As based upon physiological and pathological histology. Lecture XVIAtheromatous affection of arteries. Nutr. Rev. 47, 23-25.
175. Watanabe, H., Ohtsuka, S., Kakihana, M., and Sugishita, Y. (1992). Decreased aortic compliance aggravates subendocardial ischaemia in dogs with stenosed coronary artery. Cardiovasc. Res. 26, 1212-1218.
176. Watson, K. E., Bostrom, K., Ravindranath, R., Lam, T., Norton, B., and Demer, L. L. (1994). TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93, 2106-2113.
177. Wayhs, R., Zelinger, A., and Raggi, P. (2002). High coronary artery calcium scores pose an extremely elevated risk for hard events. J.Am. Coll. Cardiol. 39, 225-230.
178. West, S. L., Swan, V. J., and Jamal, S. A. (2010). Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population. Clin. J. Am. Soc. Nephrol. 5, S41-S47.
179. Wong, K. K., Thavornpattanapong, P., Cheung, S. C., Sun, Z., and Tu, J. (2012). Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model. BMC Cardiovasc. Disord. 12, 7. doi: 10.1186/14712261-12-7
180. Worth, N. F., Rolfe, B. E., Song, J., and Campbell, G. R. (2001). Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil. Cytoskeleton 49, 130-145.
181. Yamada, K., Fujimoto, S., Nishiura, R., Komatsu, H., Tatsumoto, M., Sato, Y., Hara, S., Hisanaga, S., Ochiai, H., Nakao, H., and Eto, T. (2007). Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol. Dial. Transplant. 22, 2032-2037.
182. Young, E. W., Albert, J. M., Satayathum, S., Goodkin, D. A., Pisoni, R. L., Akiba, T., Akizawa, T., Kurokawa, K., Bommer, J., Piera, L., and Port, F. K. (2005). Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 67, 1179-1187.
183. Yu, S. Y. (1974). Calcification processes in atherosclerosis. Adv. Exp. Med. Biol. 43, 403-425.
184. Zavaczki, E., Jeney, V., Agarwal, A., Zarjou, A., Oros, M., Katko, M., Varga, Z., Balla, G., and Balla, J. (2011). Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int. 80, 731-739.
185. Zhou, G., Kandala, J. C., Tyagi, S. C., Katwa, L. C., and Weber, K. T. (1996). Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol. Cell. Biochem. 154, 171-178.
186. Zhu, D., Mackenzie, N. C. W., Millán, J. L., Farquharson, C., and MacRae, V. E. (2011). The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE 6, e19595. doi:10.1371/journal.pone.0019595